| # | Drug | Count |
|---|---|---|
| 0 | ALIROCUMAB | 12 |
| 1 | COPPER | 11 |
| 2 | ETONOGESTREL | 3 |
| 3 | FOSCARBIDOPA/FOSLEVODOPA | 3 |
| 4 | ONABOTULINUMTOXINA | 3 |
| 5 | ETANERCEPT | 2 |
| 6 | FENTANYL | 2 |
| 7 | GLATIRAMER ACETATE | 2 |
| 8 | SPIRONOLACTONE | 2 |
| 9 | TRIAMCINOLONE ACETONIDE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CANGRELOR | 1 | 0.0025 |
| 1 | LEVONORGESTREL/ETHINYL ESTRADIOL | 1 | 0.0009 |
| 2 | ALIROCUMAB | 12 | 0.0005 |
| 3 | FOSCARBIDOPA/FOSLEVODOPA | 3 | 0.0003 |
| 4 | COPPER | 11 | 0.0003 |
| 5 | IMMUNE GLOBULIN INFUSION (HUMAN) | 1 | 0.0001 |
| 6 | BOTULINUM TOXIN TYPE A | 1 | 0.0001 |
| 7 | ESOMEPRAZOLE MAGNESIUM DIHYDRATE | 1 | 0.0001 |
| 8 | TRIAMCINOLONE ACETONIDE | 2 | 0.0001 |
| 9 | ETONOGESTREL | 3 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | PCSK9 Inhibitor [EPC] | 13 |
| 1 | Copper-containing Intrauterine Device [EPC] | 11 |
| 2 | Acetylcholine Release Inhibitor [EPC] | 4 |
| 3 | Neuromuscular Blocker [EPC] | 4 |
| 4 | Progestin [EPC] | 4 |
| 5 | Aldosterone Antagonist [EPC] | 2 |
| 6 | Corticosteroid [EPC] | 2 |
| 7 | Estrogen [EPC] | 2 |
| 8 | Interleukin-23 Antagonist [EPC] | 2 |
| 9 | Opioid Agonist [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | PCSK9 Inhibitor [EPC] | 13 | 0.0005 |
| 1 | Copper-containing Intrauterine Device [EPC] | 11 | 0.0002 |
| 2 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 3 | Acetylcholine Release Inhibitor [EPC] | 4 | 0.0000 |
| 4 | Aromatic Amino Acid Decarboxylation Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 6 | Interleukin-17A Antagonist [EPC] | 1 | 0.0000 |
| 7 | Ester Local Anesthetic [EPC] | 1 | 0.0000 |
| 8 | Interleukin-23 Antagonist [EPC] | 2 | 0.0000 |
| 9 | Aromatic Amino Acid [EPC] | 1 | 0.0000 |